INMED PHARMACEUTICALS INC. Interest Income Short Term Investment Other
INMED PHARMACEUTICALS INC. (INM) reported Interest Income Short Term Investment Other of $1.07 thousand for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeShortTermInvestmentOther · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. interest income short term investment other for the quarter ending 2024-12-31 was $355.00, a 26.20% decline year-over-year.
- INMED PHARMACEUTICALS INC. interest income short term investment other for the quarter ending 2024-09-30 was $519.00, a 3.53% decline year-over-year.
- INMED PHARMACEUTICALS INC. interest income short term investment other for the quarter ending 2023-12-31 was $481.00, a 61.41% increase year-over-year.
- INMED PHARMACEUTICALS INC. interest income short term investment other for the quarter ending 2023-09-30 was $538.00, a 348.33% increase year-over-year.
- INMED PHARMACEUTICALS INC. interest income short term investment other for fiscal 2024 was $1.25K, a 55.67% increase from fiscal 2023.
- INMED PHARMACEUTICALS INC. interest income short term investment other for fiscal 2023 was $803.00, a 598.26% increase from fiscal 2022.
- INMED PHARMACEUTICALS INC. interest income short term investment other for fiscal 2022 was $115.00.
| Period end | Interest Income Short Term Investment Other 3 month | Interest Income Short Term Investment Other 6 month | Interest Income Short Term Investment Other 12 month |
|---|---|---|---|
| 2026-06-30 | $1.07K S-4/A · filed 2026-09-09 | ||
| 2025-06-30 | $0.00 S-4/A · filed 2026-09-09 | ||
| 2024-12-31 | $355.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $874.00 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $519.00 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $1.25K 10-K · filed 2024-09-30 | ||
| 2023-12-31 | $481.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $1.02K 10-Q · filed 2025-02-12 | |
| 2023-09-30 | $538.00 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $803.00 10-K · filed 2024-09-30 | ||
| 2022-12-31 | $298.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $418.00 10-Q · filed 2024-02-13 | |
| 2022-09-30 | $120.00 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $115.00 10-K · filed 2023-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |